Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy.

about

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy.

Item

http://www.wikidata.org/entity/Q55263553

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@en

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@nl

type

Item

label

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@en

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@nl

prefLabel

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@en

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@nl

P1476

Dasatinib-Induced Pulmonary Ar ...... h Upfront Combination Therapy.

@en

P2093

Junichi Imanishi

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Nakayama

http://www.w3.org/2001/XMLSchema#string

Kenji Kaihotsu

http://www.w3.org/2001/XMLSchema#string

Masanori Iwahashi

http://www.w3.org/2001/XMLSchema#string

Naohiko Sone

http://www.w3.org/2001/XMLSchema#string

Noriaki Emoto

http://www.w3.org/2001/XMLSchema#string

Sachiko Yoshikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.

The role of imatinib in the treatment of pulmonary hypertension.

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

Pulmonary arterial hypertension in patients treated by dasatinib.

Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib.

Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.

Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.

P304

3895197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2018/3895197

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Makoto Nishimori

Tomoyuki Honjo

P577

2018-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29888010

http://www.w3.org/2001/XMLSchema#string

P932

5985094

http://www.w3.org/2001/XMLSchema#string